$TKMR Headlines Ebola play Tekmira Pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board

Oct 2, 2014 at 1:58 PM

$TKMR Headlines

Ebola play Tekmira Pharmaceuticals shares drop 2.4% 9:35 a.m. Today - Sue Chang
Newscast: Stocks swoon to start October 6:27 p.m. Oct. 1, 2014 - MarketWatch
U.S. stocks skid; Russell 2000 in correction territory 4:34 p.m. Oct. 1, 2014 - Barbara Kollmeyer
Getting Ebola treatments to market may take time 3:04 p.m. Oct. 1, 2014 - Russ Britt
6 stocks to watch 2:08 p.m. Oct. 1, 2014 - The Trading Deck
Tekmira Pharmaceuticals shares jump 20% 9:33 a.m. Oct. 1, 2014 - Sue Chang
Profiting from the fear as the market’s best quarter of the year begins 8:58 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira may launch clinical trial of Ebola drug later this year: RBC 8:19 a.m. Oct. 1, 2014 - Ciara Linnane
Tekmira surges after Ebola report; ADP sinks 8:13 a.m. Oct. 1, 2014 - Sue Chang
Tekmira Pharmaceuticals shares up 27% in premarket trade 8:03 a.m. Oct. 1, 2014 - Ciara Linnane
FAA orders screen switch 2:33 a.m. Oct. 1, 2014 - MarketWatch
Tekmira Pharma shares pop on first U.S. Ebola case 7:43 p.m. Sept. 30, 2014 - Wallace Witkowski
Newscast: Wall Street notches winning quarter 6:31 p.m. Sept. 30, 2014 - MarketWatch
Tekmira shares jump 14% on report of U.S. Ebola case 4:48 p.m. Sept. 30, 2014 - Wallace Witkowski
End of QE turns institutions into sellers 3:19 p.m. Sept. 23, 2014 - The Trading Deck
Charting the bull-bear debate 11:50 a.m. Sept. 23, 2014 - Michael Ashbaugh
Charting the bull-bear debate 11:32 a.m. Sept. 23, 2014 - Michael Ashbaugh
Charting the next technical target: Dow 17,750 11:20 a.m. Sept. 18, 2014 - Michael Ashbaugh
Use caution when investing in Ebola-related stocks 12:26 p.m. Aug. 28, 2014 - The Trading Deck
Newscast: Stocks finish the week with a flourish 6:29 p.m. Aug. 8, 2014 - MarketWatch

GeoVax jumps on the Ebola bandwagon 10:35 a.m. Today - Seeking Alpha
Tekmira Pharmaceuticals (TKMR) Is Today's Perilous Reversal Stock 9:48 a.m. Today - TheStreet.com
Thumbs Up for REITs, Down for Ebola Stocks? 7:42 a.m. Today - Barrons.com
Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% 4:39 p.m. Oct. 1, 2014 - GuruFocus.com
Stock Market Today: Stocks Dive With Utilities the Only Winning Sector 4:36 p.m. Oct. 1, 2014 - TheStreet.com
Stock Market Today: Dow Drops 250 Points as Trouble Brews 3:29 p.m. Oct. 1, 2014 - TheStreet.com
3 Stocks Soaring on Spread of Ebola Virus Epidemic - Stocks in the News 1:48 p.m. Oct. 1, 2014 - Zacks.com
Ebola-Related Pharma Stocks Soar On First U.S. Case 1:20 p.m. Oct. 1, 2014 - Investors Business Daily
Why Tekmira Pharmaceuticals (TKMR) Stock Is Soaring Today 12:22 p.m. Oct. 1, 2014 - TheStreet.com
Stock Market Today: Stocks Decline as Investors Remain Uneasy 11:41 a.m. Oct. 1, 2014 - TheStreet.com
Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks 10:08 a.m. Oct. 1, 2014 - TheStreet.com
Today's Market: Biotech Stocks To Buy For Their Ebola Vaccines 9:35 a.m. Oct. 1, 2014 - Seeking Alpha
Stock Market Today: Futures Slip as U.S. Private Sector Adds Jobs 8:28 a.m. Oct. 1, 2014 - TheStreet.com
Heavy Trading On Tekmira Pharmaceuticals (TKMR) Before Market Open 8:22 a.m. Oct. 1, 2014 - TheStreet.com
October 1 Premarket Briefing: 10 Things You Should Know 6:49 a.m. Oct. 1, 2014 - TheStreet.com
Making Money With Charles Payne: 09/30/14 6:18 a.m. Oct. 1, 2014 - FOXBusiness
5 Ebola Stocks – Invest in Preventing a U.S. Ebola Outbreak 5:13 a.m. Oct. 1, 2014 - InvestorPlace.com
'Fast Money' Recap: Should You Invest in Ebola Vaccine Developers? 5:00 a.m. Oct. 1, 2014 - TheStreet.com
Why Tekmira Pharmaceuticals (TKMR) Stock Is Gaining in After-Hours Trading Today 5:11 p.m. Sept. 30, 2014 - TheStreet.com
Trade-Ideas: Tekmira Pharmaceuticals (TKMR) Is Today's Post-Market Leader Stock 4:52 p.m. Sept. 30, 2014 - TheStreet.com

Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 9:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 10:37 a.m. Sept. 24, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 9:39 a.m. Sept. 24, 2014 - PR Newswire - PRF
Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa 6:11 a.m. Sept. 23, 2014 - GlobeNewswire
Tekmira Establishes Regulatory Framework for Emergency Use of TKM-Ebola 9:15 a.m. Sept. 22, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 2:00 p.m. Aug. 20, 2014 - GlobeNewswire
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 4:31 p.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 4:27 p.m. May 14, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 6:46 p.m. May 7, 2014 - GlobeNewswire
Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 6:31 p.m. April 28, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Koning Vera Breast CT Gains Canada License for 3D Imaging

Shake-up in Breast Imaging: Koning Vera Gains Canadian Nod Alright, folks, game-changer alert in the breast imaging arena! Koning Health is shaking things up north of the border. The Koning Vera Breast CT system just snagged that coveted Medical Device License (MDL) from Health Canada, clearing the path for Canadian healthcare providers to use this tech marvel. And, let...

TrewUp Scores Another Inc. Power Partner Award Win

Breaking Through the Noise in B2B Nobody today would be shocked to hear business owners are practically drowning in options when it comes to B2B service providers. But amid this noisy sea, TrewUp has managed to shout louder than the rest by grabbing a 2026 Inc. Power Partner Awards win—for the second year in a row, no less. It seems like they’ve cracked some sort of...

Winter Prep: Home Safety Vital for Older Adults

Cold Weather is All About Precaution It ain't the first day at the fair when you realize winter's sneaking up, and with it, the looming concern of older family members hunkering down indoors. Executive Home Care's calling out, saying it straight: if you've got seniors in your midst, now's the time to batten down the hatches. The winter months can turn into a slippery...

New CEO at Simpli.fi: Sean McCaffrey Takes Charge

A New Captain at Simpli.fi's Helm In the fast-paced world of digital advertising, Simpli.fi isn't just sitting on the sidelines. They've gone and snagged Sean McCaffrey as their new CEO. Now, for those who remember GSTV's rise to 30,000 locations under McCaffrey, this appointment carries some serious weight. McCaffrey's Track Record: Setting the Pace McCaffrey's no...

Jackson Hewitt Aims to Recruit 15,000 Seasonal Staff

Revving Up for Tax Season: Jackson Hewitt's Hiring Push When tax season looms, the hustle can't be understated, and Jackson Hewitt is cranking it up by hunting for 15,000 new recruits to tackle this annual financial circus. Starting October 26, this hiring fest is open season across the nation, pulling out all the stops to bolster its workforce. But what does this mean...

University of Phoenix Lowers Costs for Transfer Students

The Pocket-Saving Game of Transfer Credits Here's the buzz: the University of Phoenix is putting some serious coin back into students' pockets through transfer credits. We're looking at more than $12,010 in savings per student, thanks to these policies, which is no chump change by any stretch. As over 900,000 credits were tossed into the pot, the savings side of education...

Freight Rebound Sparks Strategic M&A Opportunities

Is the Freight Recovery Here to Stay? Just when you thought trucking might have run out of gas, we're hitting a sharp turn back into growth town. For those of you dropping equity crumbs every which way but loose in the last few years, this freight lull has been brutal—like the hangover from hell. But Brown Gibbons Lang & Company’s fresh report now hints at a brighter...

AEP Boosts Dividend Amid $78 Billion Expansion Plan

Dividend Hike Sets the Stage Kicking things off with a neat little surprise, American Electric Power (NASDAQ:AEP) has decided to fatten up that dividend check to 97 cents per share—or a solid 2-cent bump. Now, that might not have you dancing on the trading floor, but it sure shows us that AEP's got intentions worth watching. We're looking at a December 10 payday, so...

DARPA Pumps $10.7M into RxMP's Hemorrhage Control Drug

RxMP Therapeutics Lands a DARPA Deal Would you look at that—RxMP Therapeutics just got handed a load of cash thanks to some good old government backing. Up to $10.7 million from DARPA is no chump change. It's like finding a lifeboat right when you're treading water out there in the big bad sea. This award under the RAPIID program is set to move the needle for RxMP’s...

IBM Backs Leena AI: Shaping Enterprise Automation

IBM's Strategic Bet on Enterprise Automation Diving into the blazing 2026 market, IBM Ventures has thrown its weight behind Leena AI, an enterprise agentic AI firm that's out to shake things up. You see, the name of the game isn't just flashy AI chatbots anymore. Companies like Leena AI are setting their sights on the back-office grunt work—the lifeblood operations in...